A Phase Ii Study Of 6-Months Apalutamide Prior To Radical Prostatectomy In Intermediate Risk Patients To Reduce The Frequency Of Pathologic Features That Drive Post-Operative Radiation Therapy
JOURNAL OF UROLOGY（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要